Murali Subramanian

825 total citations
43 papers, 571 citations indexed

About

Murali Subramanian is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Murali Subramanian has authored 43 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Murali Subramanian's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (5 papers). Murali Subramanian is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Analytical Chemistry and Chromatography (5 papers). Murali Subramanian collaborates with scholars based in India, United States and Germany. Murali Subramanian's co-authors include Rory P. Remmel, Timothy S. Tracy, Angela K. Birnbaum, Sandhya Mandlekar, Charles W. Locuson, Priyadeep Bhutani, Vishal Agrawal, Walter L. Miller, Susan J. Rosser and Amrik Basran and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and The FASEB Journal.

In The Last Decade

Murali Subramanian

39 papers receiving 551 citations

Peers

Countries citing papers authored by Murali Subramanian

Since Specialization

Citations

This map shows the geographic impact of Murali Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murali Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murali Subramanian more than expected).

Fields of papers citing papers by Murali Subramanian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murali Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murali Subramanian. The network helps show where Murali Subramanian may publish in the future.

Co-authorship network of co-authors of Murali Subramanian

This figure shows the co-authorship network connecting the top 25 collaborators of Murali Subramanian. A scholar is included among the top collaborators of Murali Subramanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murali Subramanian. Murali Subramanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydrogen/Deuterium Exchange for Chiral Stability Assessment in Acidic Methine-Containing Compounds 2025 ·Analytical Chemistry ·(unknown), (unknown), Thomas Paul, (unknown), Xiaolin Zhang, (unknown), Chandrasekar Venkataramani, (unknown), Murali Subramanian, Bernard P. Murray, Xingrong Liu, Raju Subramanian	0
2	Improving Drug Delivery While Tailoring Prodrug Activation to Modulate C_max and C_min by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of Atazanavir 2022 ·Journal of Medicinal Chemistry ·Murugaiah A. M. Subbaiah, (unknown), (unknown), (unknown), Sarmistha Halder Sinha, Sandhya Mandlekar, John F. Kadow, Susan Jenkins, Mark Krystal, Murali Subramanian, Srikanth Sridhar, (unknown), Priyadeep Bhutani, (unknown), Nicholas A. Meanwell	2
3	Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9) 2020 ·ACS Medicinal Chemistry Letters ·(unknown), Dharmpal S. Dodd, (unknown), (unknown), Honghe Wan, Shana Posy, David Critton, Stefan Ruepp, Murali Subramanian, Andrew J. Watson, Paul Davies, Gary L. Schieven, Luisa Salter–Cid, Ratika Srivastava, Debarati M. Tagore, Shailesh Dudhgaonkar, Michael A. Poss, Percy H. Carter, Alaric J. Dyckman	30
4	(Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration 2020 ·European Journal of Medicinal Chemistry ·Murugaiah A. M. Subbaiah, (unknown), (unknown), (unknown), Sarmistha Halder Sinha, Sandhya Mandlekar, (unknown), Mark Krystal, Murali Subramanian, Srikanth Sridhar, (unknown), Priyadeep Bhutani, (unknown), John F. Kadow, Nicholas A. Meanwell	5
5	Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir 2018 ·Journal of Medicinal Chemistry ·Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, (unknown), (unknown), (unknown), (unknown), Sarmistha Halder Sinha, Murali Subramanian, Sandhya Mandlekar, Srikanth Sridhar, (unknown), Priyadeep Bhutani, (unknown), (unknown), Mark Krystal, Chunfu Wang, Ramakanth Sarabu	13
6	Relative quantitation of endogenous proteins by quadrupole-time of flight and tandem mass spectrometry 2018 ·Journal of Chromatography B ·(unknown), (unknown), (unknown), (unknown), Sudha Rajagopalan, Prashant Kole, Sandhya Mandlekar, Murali Subramanian	3
7	A Novel Liquid Chromatography Tandem Mass Spectrometry Method for the Estimation of Bilirubin Glucuronides and its Application to In Vitro Enzyme Assays 2016 ·Drug Metabolism Letters ·(unknown), Murali K. Matta, (unknown), Murali Subramanian, Michael Sinz, Sandhya Mandlekar	17
8	Relapsed Hodgkin’s Lymphoma Presenting with Isolated Ulcerative Lesion on Base of Tongue 2014 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), Murali Subramanian, (unknown)	1
9	Payments in the Middle East and Africa: An overview and review of implications for corporates operating in the region 2014 ·Journal of payments strategy & systems ·Murali Subramanian	1
10	A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model 2014 ·Drug Metabolism Letters ·(unknown), (unknown), (unknown), (unknown), Murali Subramanian, (unknown), Matthew G. Soars, John J. Herbst, Roy Haskell, Punit Marathe, Sandhya Mandlekar	16
11	Characterization of Recombinantly Expressed Rat and Monkey Intestinal Alkaline Phosphatases: In Vitro Studies and In Vivo Correlations 2013 ·Drug Metabolism and Disposition ·Murali Subramanian, (unknown), (unknown), Sheelendra Pratap Singh, (unknown), Sonia Pahwa, (unknown), (unknown), (unknown), (unknown), Debarati M. Tagore, Kaushik Ghosh, Punit Marathe, Sandhya Mandlekar	6
12	Expression and Characterization of Cynomolgus Monkey Cytochrome CYP3A4 in a Novel Human Embryonic Kidney Cell–Based Mammalian System 2013 ·Drug Metabolism and Disposition ·(unknown), Priyadeep Bhutani, Kaushik Ghosh, (unknown), (unknown), (unknown), Manjunath Ramarao, Sandhya Mandlekar, Michael Sinz, A. David Rodrigues, Murali Subramanian	5
13	Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3 2012 ·Pharmacogenetics and Genomics ·Murali Subramanian, Vishal Agrawal, (unknown), (unknown), Walter L. Miller, Timothy S. Tracy	34
14	Rituximab-induced subacute interstitial pneumonitis: A case report and review of literature 2010 ·Journal of Cancer Research and Therapeutics ·Murali Subramanian, R Manjunath, (unknown), (unknown)	5
15	CYP2C91B Promoter Polymorphisms, in Linkage with CYP2C192, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Amarjit S. Chaudhry, Thomas Urban, Jatinder K. Lamba, Angela K. Birnbaum, Rory P. Remmel, Murali Subramanian, Stephen C. Strom, Joyce H. S. You, Dalia Kasperavičiūtė, Claudia B. Catarino, Rodney A. Radtke, Sanjay M. Sisodiya, David B. Goldstein, Erin G. Schuetz	40
16	CYP2D6-CYP2C9 Protein-Protein Interactions and Isoform-Selective Effects on Substrate Binding and Catalysis 2009 ·Drug Metabolism and Disposition ·Murali Subramanian, (unknown), Charles W. Locuson, Timothy S. Tracy	41
17	Electrocatalytic Drug Metabolism by CYP2C9 Bonded to A Self-Assembled Monolayer-Modified Electrode 2009 ·Drug Metabolism and Disposition ·Mingli Yang, (unknown), Lance Wollenberg, Xinqi Chen, Murali Subramanian, Timothy S. Tracy, David Lederman, Peter M. Gannett, Nianqiang Wu	38
18	Embryonal rhabdomyosarcoma of the chest wall: A case report and review of the literature 2008 ·Indian Journal of Pathology and Microbiology ·(unknown), K Harish, (unknown), Murali Subramanian, (unknown)	3
19	High-Speed Simultaneous Determination of Nine Antiepileptic Drugs Using Liquid Chromatography-Mass Spectrometry 2008 ·Therapeutic Drug Monitoring ·Murali Subramanian, Angela K. Birnbaum, Rory P. Remmel	96
20	Enhanced Transformation of TNT by Tobacco Plants Expressing a Bacterial Nitroreductase 2007 ·International Journal of Phytoremediation ·(unknown), Murali Subramanian, Susan J. Rosser, Amrik Basran, J. A. H. Murray, Jacqueline V. Shanks, Neil C. Bruce	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact